ABBVIE (4AB BE) stock market data APIs
€183.1408
8.76(4.8%)
as of March 18, 2026
Try our APIs with
free plan!
ABBVIE Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for 4AB.BE.
Prev. Close
183.1408
Open
191.9016
High
192.575
Low
179.099
52 wk Range
143.4918-204.957
Market Cap
196 410 M
Dividends (Yield)
0.0457
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ABBVIE data using free add-ons & libraries
Get ABBVIE Fundamental Data
ABBVIE Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ABBVIE News
New
AbbVie’s CLL Breakthrough And US$380m Build Out Test Valuation
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. AbbVie received FDA approva...
RBC Capital Launches AbbVie (ABBV) Coverage, Expects Shares to Outperform Amid Competitive Fears
AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Affordable Dividend Stocks to Buy According to Analysts.RBC Capital Launches AbbVie (ABBV) Coverage, Expects Shares to Outperform Amid Competitive...
Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie
Investing.com -- RBC analysts say U.S. large cap pharma offers defensive exposure and earnings upside as artificial intelligence reshapes drug development. Pharma stocks trade at about a 25% discount...
How Pipeline Shifts And Competition Are Reshaping The AbbVie (ABBV) Investment Narrative
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AbbVie’s fair value estimate has been updated slightly, moving from about US$244.96 to ab...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
